Skin Treatment
Skin Treatment
1
1-2
1
1-2

Terbinafine Hydrochloride Tablets

GMP Certified · Fungicidal · 10mg/kg Once Daily · OEM/ODM Available
Oral systemic antifungal tablets for dogs — fungicidal action against ringworm and dermatophyte infections. 

Terbinafine Hydrochloride Tablets for Dogs and Cats | Oral Antifungal Ringworm Treatment

Terbinafine Hydrochloride Tablets is an oral antifungal medication used to treat dermatophyte infections of the skin, hair, and nails in dogs .It is highly effective against ringworm (Microsporum canisTrichophyton mentagrophytes) and other superficial fungal infections. As a trusted Skin Treatment, it works by inhibiting squalene epoxidase, leading to fungal cell death.
WERVIC, a professional veterinary supplier, offers high‑purity Terbinafine Hydrochloride Tablets with consistent quality, precise dosing, and excellent bioavailability – ideal for veterinary clinics, shelters, and distributors.

通用.png

What Terbinafine Tablets Treat in Dogs

Terbinafine hydrochloride tablets are indicated for the systemic treatment of dermatophyte fungal infections in dogs — primarily ringworm (Microsporum canis, Trichophyton mentagrophytes) affecting the skin, hair follicles, and nails.
When oral tablets are the right choice over topical-only treatment:

Widespread lesions covering multiple body areas where topical spray coverage is impractical
Deep follicular infections where topical agents cannot penetrate to the site of infection
Recurring or chronic ringworm that has failed topical monotherapy
Shelter or multi-dog environments with active ringworm outbreaks — combined oral and topical protocol for systematic clearance
Long-coated breeds where topical application to skin surface is difficult
Dogs that failed or showed intolerance to itraconazole or ketoconazole

Mechanism of Action — Fungicidal, Not Fungistatic

Terbinafine selectively inhibits fungal squalene epoxidase, an enzyme essential to ergosterol biosynthesis in the fungal cell membrane. The result is a dual mechanism of cell death: squalene accumulates to toxic concentrations within the fungal cell while ergosterol is simultaneously depleted. The fungal cell membrane fails structurally and the organism dies directly.
Azole-class antifungals (itraconazole, ketoconazole, fluconazole) work differently — they inhibit a later step in ergosterol synthesis via lanosterol 14α-demethylase. This produces a fungistatic effect: fungal growth is arrested but the organism is not killed directly. Clearance depends on the animal's immune system finishing the job.

Parameter Terbinafine (Allylamine) Azoles (Itraconazole / Ketoconazole)
Mechanism of Action Inhibits Squalene Epoxidase Inhibits Lanosterol 14α-Demethylase
Antifungal Activity Fungicidal (Kills Fungi) Fungistatic (Inhibits Fungal Growth)
Fungal Clearance Direct Fungicidal Activity Combined with Host Immune Response Primarily Dependent on Host Immune Response
Risk of Relapse Lower Comparatively Higher
Hepatotoxicity Generally Lower Than Ketoconazole Ketoconazole Has a Higher Risk of Hepatotoxicity
Drug Interactions Fewer Clinically Significant Drug Interactions More CYP450-Mediated Drug Interactions

Product Specifications

Parameter Details
Active Ingredient Terbinafine Hydrochloride
Strength 0.1 g per Tablet (Calculated as C₂₁H₂₅N·HCl)
Appearance Light Yellow Tablet
Drug Class Allylamine Antifungal
Target Species Dogs (For Cats, Terbinafine Spray Is Recommended for Topical Use)
Administration Route Oral Administration
Recommended Dosing Frequency Once Daily
Recommended Treatment Duration 14–28 Consecutive Days*
Storage Conditions Store in a Cool, Dry Place and Protect from Light. Keep Tightly Sealed.
Shelf Life 24 Months
Withdrawal Period Not Applicable**
Packaging Standard Export Packaging or Customized OEM/Private Label Packaging Available

Dosing Protocol for Dogs

Standard dose: 10 mg terbinafine hydrochloride per 1 kg body weight, orally, once daily.
Treatment duration: 14 to 28 consecutive days. Do not discontinue early even if lesions appear to resolve — dermatophyte clearance requires completing the full course to prevent relapse.

Practical dosing table:

Dog Weight Recommended Daily Dose Tablet Administration Guide
2.5–5 kg 25–50 mg ½ Tablet*
5–10 kg 50–100 mg ½–1 Tablet
10–20 kg 100–200 mg 1–2 Tablets
20–30 kg 200–300 mg 2–3 Tablets
Over 30 kg 300 mg or Above Dosage Determined by a Licensed Veterinarian

Administration guidance: Give with food to minimize the risk of mild GI upset. Administer at the same time each day to maintain consistent plasma drug levels.

Dual-Format Treatment System

Terbinafine Hydrochloride Tablets (this product) — oral systemic action. Targets the infection from inside out. Preferred for widespread, deep, or recurring infections, and for cases where topical coverage is impractical.
Terbinafine Hydrochloride Spray — topical fungicidal spray. Direct surface-level lesion treatment. Applied twice daily to the affected skin area.
Combined protocol: for moderate to severe ringworm, veterinarians routinely co-prescribe both. The spray addresses surface lesions rapidly while the tablet clears the systemic infection.

Wholesale & OEM Information

Who we supply:

Veterinary pharmaceutical distributors adding oral antifungal SKUs to their dermatology range
Pet health importers sourcing terbinafine as a generic alternative to brand-leader oral antifungals
Veterinary clinic chains and shelter supply procurement teams
Private label brands building companion animal dermatology lines
International distributors serving markets with high ringworm prevalence (Southeast Asia, Latin America, Middle East, parts of Eastern Europe)

OEM/ODM scope:

Custom brand name, logo, and label design in any language (including Portuguese for Brazil/LATAM markets)
Custom tablet strength and coating
Custom packaging: blister count, box dimensions, insert/leaflet language
Regulatory dossier support: GMP certificate, Certificate of Analysis, stability data, efficacy documentation for EU, UK, AU, Southeast Asia, LATAM, Middle East

Lead time: 30–45 days standard.
MOQ: Flexible — contact us with your target market and volume for a project-specific quotation.

Precautions 

Contraindications:

Do not use in breeding dogs, pregnant dogs, lactating bitches, or puppies under 6 months of age (safety studies not conducted)
Do not use in animals with confirmed hepatic or renal insufficiency
Use with caution in dogs under 2.5 kg — administer only under veterinary guidance

Monitoring:
Liver function testing is recommended 2 weeks after initiating treatment, particularly for dogs on courses longer than 14 days. This is standard practice for oral antifungal therapy and should be communicated clearly in product labeling and downstream educational materials.
Adverse reactions:
Mild and transient gastrointestinal effects (reduced appetite, occasional vomiting) are the most commonly reported reactions. These typically resolve without discontinuing treatment. Serious adverse events are rare at therapeutic doses.

FAQ

What does terbinafine treat in dogs?
Dermatophyte fungal infections — primarily ringworm caused by Microsporum canis and Trichophyton mentagrophytes. Indicated for skin, hair follicle, and nail infections. Most commonly used for widespread, recurring, or treatment-resistant ringworm cases.
What is the terbinafine dosage for dogs?
10 mg per kg body weight, orally, once daily for 14–28 consecutive days. Administer with food. Do not use in dogs under 2.5 kg without veterinary guidance.
Is terbinafine better than itraconazole for dogs?
Both are effective oral antifungals for ringworm. Terbinafine's key advantages are fungicidal action (kills fungi directly rather than inhibiting growth), a lower hepatotoxicity profile than ketoconazole, and fewer drug interactions than azole-class antifungals. Choice depends on clinical history and the prescribing veterinarian's preference.
Can terbinafine tablets be used together with the spray?
Yes — combined oral and topical terbinafine protocol is the standard approach for moderate to severe ringworm. The tablet provides systemic clearance while the spray addresses surface lesions. Both products are manufactured at our GMP-certified facility.
Is liver monitoring required?
Yes. Liver function testing is recommended 2 weeks after starting treatment. This is standard practice for oral antifungal therapy in dogs. Do not use in dogs with existing hepatic insufficiency.
Is OEM/private label available?
Yes — full OEM service including custom branding, tablet strength, packaging, and regulatory dossier support. Available in any language including Portuguese for LATAM markets.
What is the MOQ for wholesale orders?
MOQ is flexible by configuration. Contact us with your estimated volume and target market for project-specific pricing.

1
Imidacloprid and Moxidectin Spot-on Solutions for Dogs
Imidacloprid and Moxidectin Spot-on Solutions for Dogs
Introducing Imidacloprid and Moxidectin Spot-on Solutions for Dogs—your ultimate defense against internal and external parasites. This powerful duo not only prevents but also treats pesky infestations, ensuring your furry friend stays healthy and happy. Trust in this effective solution to safeguard your dog from unwanted invaders with every application.
JAK MULTI Oclacitinib Maleate Tablets for Dogs
JAK MULTI Oclacitinib Maleate Tablets for Dogs
Introducing Oclacitinib Maleate Tablets—specifically formulated to provide relief from pruritus due to allergic dermatitis and atopic dermatitis in dogs. These effective tablets help restore your furry friend's comfort and quality of life, ensuring they can enjoy their days free from the discomfort of itching. Celebrate their happiness with Oclacitinib!
JAK PLUS Compound Oclacitinib Maleate Chewable Tablets
JAK PLUS Compound Oclacitinib Maleate Chewable Tablets
Introducing Compound Oclacitinib Maleate Chewable Tablets, the effective solution for controlling pruritus caused by allergic dermatitis and managing atopic dermatitis in dogs. With its easy-to-administer chewable format, these tablets provide rapid relief, ensuring your furry friend feels comfortable and happy. Give your dog the relief they deserve!
Viclaner chewable tablets for dog
Viclaner chewable tablets for dog
Character : Light brown to dark brown round piece Main ingredient: Fluralaner 112.5mg 250mg 500mg 1000mg 1400mg Indication: It is used to treat flea and tick infection on the dog's body surface, and can also assist in the treatment of allergic dermatitis caused by fleas.
Terbinafine Hydrochloride Spray
Terbinafine Hydrochloride Spray
Terbinafine hydrochloride is a broad-spectrum antifungal drug of the allylamine class.
Terbinafine Hydrochloride Tablets
Terbinafine Hydrochloride Tablets
Terbinafine hydrochloride is an allylamine-class drug with broad-spectrum antifungal activity.
Imidacloprid and Moxidectin Spot-on Solutions for Cats
Imidacloprid and Moxidectin Spot-on Solutions for Cats
Introducing our Imidacloprid and Moxidectin Spot-on Solution for Cats—your go-to solution for comprehensive parasitic protection! This powerful formula prevents and treats flea infections, ear mites, and gastrointestinal nematodes, while also preventing heartworm and aiding in the relief of flea-induced allergic dermatitis. Keep your feline friend healthy and happy!
GET IN TOUCH
Needs Help? Let’s Get in Touch
    • aaa--bbbb
    • Afghanistan
    • Albania
    • Algeria
    • American Samoa
    • Andorra
    • Angola
    • Anguilla
    • Antarctica
    • Antigua and Barbuda
    • Argentina
    • Armenia
    • Aruba
    • Australia
    • Austria
    • Azerbaijan
    • Bahamas
    • Bahrain
    • Bangladesh
    • Barbados
    • Belarus
    • Belgium
    • Belize
    • Benin
    • Bermuda
    • BBhutan
    • Bolivia
    • Bosnia and Herzegovina
    • Botswana
    • Bouvet Island
    • Brazil
    • British Indian Ocean Territory
    • Brunei Darussalam
    • Bulgaria
    • Burkina Faso
    • Burundi
    • Cambodia
    • Cameroon
    • Canada
    • Cape Verde
    • Cayman Islands
    • Central African Republic
    • Chad
    • Chile
    • China
    • Christmas Island
    • Cocos (Keeling) Islands
    • Colombia
    • Comoros
    • Congo
    • Cook Islands
    • Costa Rica
    • Cote D'Ivoire
    • Croatia
    • Cuba
    • Cyprus
    • Czech Republic
    • Denmark
    • Djibouti
    • Dominica
    • East Timor
    • Ecuador
    • Egypt
    • El Salvador
    • Equatorial Guinea
    • Eritrea
    • Estonia
    • Ethiopia
    • Falkland Islands (Malvinas)
    • Faroe Islands
    • Fiji
    • Finland
    • France, Metropolitan
    • French Guiana
    • French Polynesia
    • Gabon
    • Gambia
    • Georgia
    • Germany
    • Ghana
    • Gibraltar
    • Greece
    • Greenland
    • Grenada
    • Guadeloupe
    • Guam
    • Guatemala
    • Guinea
    • Guinea-Bissau
    • Guyana
    • Haiti
    • Honduras
    • Hong Kong, China
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Iran (Islamic Republic of)
    • Iraq
    • Ireland
    • Israel
    • Italy
    • Jamaica
    • Japan
    • Jordan
    • Kazakhstan
    • Kenya
    • Kiribati
    • North Korea
    • South Korea
    • Kuwait
    • Kyrgyzstan
    • Lao People's Democratic Republic
    • Latvia
    • Lebanon
    • Lesotho
    • Liberia
    • Libyan Arab Jamahiriya
    • Liechtenstein
    • Lithuania
    • Luxembourg
    • Macau
    • Madagascar
    • Malawi
    • Malaysia
    • Maldives
    • Mali
    • Malta
    • Marshall Islands
    • Martinique
    • Mauritania
    • Mauritius
    • Mayotte
    • Mexico
    • Micronesia
    • Moldova
    • Monaco
    • Mongolia
    • Montserrat
    • Morocco
    • Mozambique
    • Myanmar
    • Namibia
    • Nauru
    • Nepal
    • Netherlands
    • New Caledonia
    • New Zealand
    • Nicaragua
    • Niger
    • Nigeria
    • Niue
    • Norfolk Island
    • Northern Mariana Islands
    • Norway
    • Oman
    • Pakistan
    • Palau
    • Panama
    • Papua New Guinea
    • Paraguay
    • Peru
    • Philippines
    • Pitcairn
    • Poland
    • Portugal
    • Puerto Rico
    • Qatar
    • Reunion
    • Romania
    • Russian Federation
    • Rwanda
    • Saint Kitts and Nevis
    • Saint Lucia
    • Saint Vincent and the Grenadines
    • Samoa
    • San Marino
    • Saudi Arabia
    • Senegal
    • Seychelles
    • Sierra Leone
    • Singapore
    • Slovak Republic
    • Slovenia
    • Solomon Islands
    • Somalia
    • South Africa
    • Spain
    • Sri Lanka
    • St. Helena
    • Sudan
    • Suriname
    • Swaziland
    • Sweden
    • Switzerland
    • Syrian Arab Republic
    • Taiwan, China
    • Tajikistan
    • Tanzania
    • Thailand
    • Togo
    • Tokelau
    • Tonga
    • Trinidad and Tobago
    • Tunisia
    • Turkey
    • Turkmenistan
    • Turks and Caicos Islands
    • Tuvalu
    • Uganda
    • Ukraine
    • United Arab Emirates
    • United Kingdom
    • United States
    • Uruguay
    • Uzbekistan
    • Vanuatu
    • Vatican City State (Holy See)
    • Venezuela
    • Viet Nam
    • Virgin Islands (U.S.)
    • Wallis and Futuna Islands
    • Western Sahara
    • Yemen
    • Zambia
    • Zimbabwe
    • Montenegro
    • Serbia
    • Palestine
    • South Sudan
    • Jersey